HARP
HARP company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
3 articles
Price performance
Recent trading
Newsroom
Latest HARP coverage
Is It The Rise Of Clinical Stage Pharma Small Caps? Decoding The Harpoon Therapeutics Acquisition By Merck!
Clinical stage biopharma small-cap, Harpoon Therapeutics has entered the spotlight with pharma giant, Merck agreeing to acquire the company for a staggering $680 million.
Additional heart imaging valuable for women with unexplained heart attacks
[ad_1] Research Highlights: Combining diagnostic imaging methods can detect the underlying cause of heart attack in women who did not have blocked arteries. This international, diagnostic, prospective, observational study suggested that additional heart imaging is feasible and has the potential to guide medical therapy to prevent subsequent heart attac
Harpoon files $86M IPO to help fund its T-cell engager platform
[ad_1] Fresh off elevating $70 million by a collection C spherical simply over a month in the past, Harpoon Therapeutics introduced it should go public with an $86.25 million IPO to additional help its portfolio of early-stage T-cell engagers geared toward strong tumors. The South San Francisco-based firm filed confidentially with the SEC in late ...